陈凯先院士:羟氯喹治疗新冠肺炎临床试验启动 - 2020年02月14日

Shanghai has launched clinical trials to test the efficiency of an anti-rheumatic drug in the treatment of novel coronavirus pneumonia, according to academician Chen Kaixian.
As yet, there is no specific medicine for treating the virus. As new drug development takes time, local scientists have been researching existing drugs in the possible treatment of the novel coronavirus, Chen, of the China Academy of Sciences, said at a city press conference on Thursday.
Hydroxychloroquine, which can decrease the pain and swelling caused by arthritis, has been approved for clinical trials by the Ministry of Science and Technology and the National Health Commission.